An Overview on Evidence-Based Medicine and Medical Informatics in Traditional Chinese Medicine Practice

  • Kelvin Chan
  • Josiah Poon
  • Simon K. Poon
  • Miao Jiang
  • Aiping Lu
Chapter
First Online:

Abstract

This chapter describes how best to look at the evidence-base of the rich experience-based disciplines of traditional Chinese medicine in this era of highly advance of biomedicine, science-orientated development and information technology. It is emphasized that there is a need in using modified modalities that can focus on the inclusion of holistic TCM diagnosis and treatment outcomes of individual patients in randomized clinical trial for TCM products studies and that in practice individual patients’ reported outcomes linked with biomedical parameters may provide evidence-base treatment efficacy. Using TCM formulae for treatment of female infertility as an example for IT contribution to data analysis, it is suggested that continuing feedback between practitioners in each field will help refining IT analysis of TCM informatics in general.

Keywords

Traditional Chinese Medicine Chinese Herbal Medicine Conventional Medicine Synergy Index Traditional Chinese Medicine Theory 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access

References

  1. C. Acquadro, R. Berzon, D. Dubois, N.K. Leidy, P. Marquis, D. Revicki, M. Rothman, Incorporating the patient’s perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health 6, 522–531 (2003)CrossRefGoogle Scholar
  2. E. Ainy, P. Mirmiran, S. Zahedi Asl, F. Azizi, Prevalence of metabolic syndrome during menopausal transition Tehranian women: Tehran Lipid and Glucose Study (TLGS). Maturitas 58, 150–155 (2007)CrossRefGoogle Scholar
  3. Z.X. Bian, D. Moher, S. Dagenais, Y.P. Li, L. Liu, T.X. Wu, J.X. Miao, Improving the quality of randomized controlled trials in Chinese herbal medicine, part II: control group design. Zhong xi yi jie he xue bao (J. Chin. Integr. Med.) 4, 130–136 (2006)CrossRefGoogle Scholar
  4. S. Campbell, M. Whitehead, Oestrogen therapy and the menopausal syndrome. Clin. Obstet. Gynaecol. 4, 31–47 (1977)Google Scholar
  5. K. Chan, Chinese medicinal materials and their interface with Western medical concepts. J. Ethnopharmacol. 96, 1–18 (2005)CrossRefGoogle Scholar
  6. K. Chan, L. Cheung, Interactions between Chinese Herbal Medicinal Products and Orthodox Drugs, Taylor & Francis Group, September 11, 2000 by CRC Press ISBN 9789057024139 Ca#TF3184Google Scholar
  7. M. Deng, X.Q. Sui, S.B. Zhu, W. Ma, Y. Xu, Z.M. Chen, Clinical observation on the treatment of atrial fibrillation with amiodarone combined with Shenmai injection (). Chin. J. Integr. Med. 16, 453–456 (2010)CrossRefGoogle Scholar
  8. L. Donald, Patient-Reported Outcomes (PROs): an organizing tool for concepts, measures, and applications. Qol Newslett. 31, 1–5 (2003)Google Scholar
  9. F.Y. Edgeworth, Mathematical Psychics: An Essay on the Application of Mathematics to the Moral Sciences (C.K. Paul & co., London, 1881)Google Scholar
  10. E. Ernst, Methodological aspects of Traditional Chinese Medicine (TCM). Ann. Acad. Med. Singapore 35, 773–774 (2006)Google Scholar
  11. E. Ernst, M.H. Pittler, Alternative therapy bias. Nature 385, 480 (1997)CrossRefGoogle Scholar
  12. A.Y. Fan, L. Lao, R.X. Zhang, A.N. Zhou, B.M. Berman, Preclinical safety evaluation of the aqueous acetone extract of Chinese herbal formula modified Huo Luo Xiao Ling Dan. Zhong Xi Yi Jie He Xue Bao 8, 438–447 (2010)CrossRefGoogle Scholar
  13. B. Flaws, The Treatment of Modern Western Diseases with Chinese Medicine (Blue Poppy Press, Boulder, 2005)Google Scholar
  14. Q. Geng, B.D. Lu, X.J. Huang, Effect of modified tianxiong powder in treating oligospermia and asthenospermia. Zhongguo Zhong Xi Yi Jie He Za Zhi 30, 496–498 (2010)Google Scholar
  15. Y. Gong, Q. Zha, L. Li, Y. Liu, B. Yang, L. Liu, A. Lu, Y. Lin, M. Jiang, Efficacy and safety of Fufangkushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: a double-blinded and randomized study. J. Ethnopharmacol. 141, 592–598 (2012)CrossRefGoogle Scholar
  16. F.L. Guo, C. Han, Q.P. Liu, L.J. Liu, Clinical observation on the effect of Tongbi Heji plus syndrome differentiation treatment for 90 rheumatoid arthritis patients. J. Tradit. Chin. Med. 10, 34–37 (2008)Google Scholar
  17. Y. He, A. Lu, Y. Zha, X. Yan, Y. Song, S. Zeng, W. Liu, W. Zhu, L. Su, X. Feng, X. Qian, C. Lu, Correlations between symptoms as assessed in traditional Chinese medicine (TCM) and ACR20 efficacy response: a comparison study in 396 patients with rheumatoid arthritis treated with TCM or Western medicine. J. Clin. Rheumatol. 13, 317–321 (2007)CrossRefGoogle Scholar
  18. S.C. Hsieh, J.N. Lai, P.C. Chen, C.C. Chen, H.J. Chen, J.D. Wang, Is Duhuo Jisheng Tang containing Xixin safe? A four-week safety study. Chin. Med. 5, 6 (2010)CrossRefGoogle Scholar
  19. A.R. Jadad, D. Rennie, The randomized controlled trial gets a middle-aged checkup. JAMA 279, 319–320 (1998)CrossRefGoogle Scholar
  20. G. Jia, M.B. Meng, Z.W. Huang, X. Qing, W. Lei, X.N. Yang, S.S. Liu, J.C. Diao, S.Y. Hu, B.H. Lin, R.M. Zhang, Treatment of functional constipation with the Yun-chang capsule: a double-blind, randomized, placebo-controlled, dose-escalation trial. J. Gastroenterol. Hepatol. 25, 487–493 (2010)CrossRefGoogle Scholar
  21. M. Jiang, J. Zhao, A. Lu, Q. Zha, Y. He, Does gastrointestinal adverse drug reaction influence therapeutic effect in the treatment of rheumatoid arthritis? J. Altern. Complement. Med. 16, 143–144 (2010)CrossRefGoogle Scholar
  22. M. Jiang, C. Lu, G. Chen, C. Xiao, Q. Zha, X. Niu, S. Chen, A. Lu, Understanding the molecular mechanism of interventions in treating rheumatoid arthritis patients with corresponding traditional Chinese medicine patterns based on bioinformatics approach. Evid. Based Complement. Alternat. Med.: eCAM 2012, 129452 (2012a)Google Scholar
  23. M. Jiang, C. Lu, C. Zhang, J. Yang, Y. Tan, A. Lu, K. Chan, Syndrome differentiation in modern research of traditional Chinese medicine. J. Ethnopharmacol. 140, 634–642 (2012b)CrossRefGoogle Scholar
  24. M. Jiang, C. Zhang, G. Zheng, H. Guo, L. Li, J. Yang, C. Lu, W. Jia, A. Lu, Traditional Chinese medicine Zheng in the era of evidence-based medicine: a literature analysis. Evid. Based Complement. Alternat. Med.: eCAM 2012, 409568 (2012c)Google Scholar
  25. M. Jun, C. Foote, J. Lv, B. Neal, A. Patel, S.J. Nicholls, D.E. Grobbee, A. Cass, J. Chalmers, V. Perkovic, Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet 375, 1875–1884 (2010)CrossRefGoogle Scholar
  26. R. Ko, Adverse reactions to watch for in patients using herbal remedies. West. J. Med. 171, 181–186 (1999)Google Scholar
  27. K.F. Leung, F.B. Liu, L. Zhao, J.Q. Fang, K. Chan, L.Z. Lin, Development and validation of the Chinese quality of life instrument. Health Qual. Life Outcomes 3, 26 (2005)CrossRefGoogle Scholar
  28. X. Li, C. Zhang, Q. Shi, T. Yang, Q. Zhu, Y. Tian, C. Lu, Z. Zhang, Z. Jiang, H. Zhou, X. Wen, H. Yang, X. Ding, L. Liang, Y. Liu, Y. Wang, A. Lu, Improving the efficacy of conventional therapy by adding andrographolide sulfonate in the treatment of severe hand, foot, and mouth disease: a randomized controlled trial. Evid. Based Complement. Alternat. Med.: eCAM 2013, 316250 (2013)Google Scholar
  29. J.P. Liu, M. Zhang, W.Y. Wang, S. Grimsgaard, Chinese herbal medicines for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 3, CD003642 (2004)Google Scholar
  30. T. Liu, C. Liu, P.X. Gao, C.P. Yu, Clinical study on method of “tonifying the lung to check the liver” for treatment of chronic cholecystitis. Chin. Acupunct. Moxib. 12, 29–30 (2005)MATHGoogle Scholar
  31. D. Liu, H. Lin, X. Wang, W. Zhou, G. Chen, W. Guo, J. Ye, Z. Xu, H. Chen, X.M. Chen, Z. Lai, C. Xiang, Influence of removing blood stasis and tonifying liver and kidney method on quality of life in patients with essential hypertension: randomized controlled observation. Chin. J. Clin. Rehabil. 23, 9–12 (2006a)Google Scholar
  32. J.P. Liu, M. Yang, Y.X. Liu, M.L. Wei, S. Grimsgaard, Herbal medicines for treatment of irritable bowel syndrome. Cochrane Database Syst. Rev. 25(1), CD004116 (2006b)Google Scholar
  33. A.P. Lu, K.J. Chen, Integrative medicine in clinical practice: from pattern differentiation in traditional Chinese medicine to disease treatment. Chin. J. Integr. Med. 15, 152 (2009)CrossRefGoogle Scholar
  34. A.P. Lu, H.W. Jia, C. Xiao, Q.P. Lu, Theory of traditional Chinese medicine and therapeutic method of diseases. World J. Gastroenterol. 10, 1854–1856 (2004)Google Scholar
  35. A.P. Lu, S.S. Zhang, Q.L. Zha, D.H. Ju, H. Wu, H.W. Jia, C. Xiao, S. Li, H. Jian, Correlation between CD4, CD8 cell infiltration in gastric mucosa, Helicobacter pylori infection and symptoms in patients with chronic gastritis. World J. Gastroenterol. 11, 2486–2490 (2005)Google Scholar
  36. A.P. Lu, X.R. Ding, K.J. Chen, Current situation and progress in integrative medicine in China. Chin. J. Integr. Med. 14, 234–240 (2008)CrossRefGoogle Scholar
  37. C. Lu, X. Niu, C. Xiao, G. Chen, Q. Zha, H. Guo, M. Jiang, A. Lu, Network-based gene expression biomarkers for cold and heat patterns of rheumatoid arthritis in traditional Chinese medicine. Evid. Based Complement. Alternat. Med.: eCAM 2012, 203043 (2012a)Google Scholar
  38. C. Lu, C. Xiao, G. Chen, M. Jiang, Q. Zha, X. Yan, W. Kong, A. Lu, Cold and heat pattern of rheumatoid arthritis in traditional Chinese medicine: distinct molecular signatures indentified by microarray expression profiles in CD4-positive T cell. Rheumatol. Int. 32, 61–68 (2012b)CrossRefGoogle Scholar
  39. K.S. Poon, J. Poon, M. McGrane, X. Zhou, P. Kwan, R. Zhang, B. Liu, J. Gao, C. Loy, K. Chan, D. and Sze, A Novel Approach in Discovering Significant Interactions from TCM Patient Prescription Data, International Journal of Data Mining and Bioinformatics, 5(4), 353–367 (2011)Google Scholar
  40. V.R. Mesch, L.E. Boero, N.O. Siseles, M. Royer, M. Prada, F. Sayegh, L. Schreier, H.J. Benencia, G.A. Berg, Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status. Climacteric 9, 40–48 (2006)CrossRefGoogle Scholar
  41. U.A. Meyer, Pharmacogenetics and adverse drug reactions. Lancet 356, 1667–1671 (2000)CrossRefGoogle Scholar
  42. G. Nestler, Traditional Chinese medicine. Med. Clin. North Am. 86, 63–73 (2002)CrossRefGoogle Scholar
  43. K.A. Phillips, D.L. Veenstra, E. Oren, J.K. Lee, W. Sadee, Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA 286, 2270–2279 (2001)CrossRefGoogle Scholar
  44. X.Y. Qin, X.X. Li, S. Suteanu, Comparative study on Chinese medicine and western medicine for treatment of prolapse of lumbar intervertebral disc. Chin. Acupunct. Moxib. 5, 53–56 (2007)Google Scholar
  45. H. Qing, S.F. Wang, J.M. Fan, I.L.H. Zha, J.Y. Mao, L.J. Sun, R.L. Zhang, Multi-center clinical study of Rhadiola extract injection on the treatment of stable angina pectoris of coronary heart disease with cardiac blood stasis syndrome. Chin. Tradit. Pat. Med. 3, 20–33 (2009)Google Scholar
  46. K. Rothman, The estimation of synergy or antagonism. Am. J. Epidemiol. 103, 506–511 (1976)Google Scholar
  47. K.F. Schulz, I. Chalmers, R.J. Hayes, D.G. Altman, Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273, 408–412 (1995)CrossRefGoogle Scholar
  48. Y.H. Shen, R. Nahas, Complementary and alternative medicine for treatment of irritable bowel syndrome. Can. Fam. Physician Medecin de famille canadien 55, 143–148 (2009)Google Scholar
  49. C. Stevinson, M.H. Pittler, E. Ernst, Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann. Intern. Med. 133, 420–429 (2000)CrossRefGoogle Scholar
  50. S.C. Sze, K.L. Wong, W.K. Liu, T.B. Ng, J.H. Wong, H.P. Cheung, C.M. Yow, E.S. Chu, Q. Liu, Y.M. Hu, K.W. Tsang, W.S. Lee, Y. Tong, Regulation of p21, MMP-1, and MDR-1 expression in human colon carcinoma HT29 by Tian Xian Liquid, a Chinese medicine formula. In vitro and in vivo. Integr. Cancer Ther. 10, 58–69 (2011)Google Scholar
  51. J.L. Tang, S.Y. Zhan, E. Ernst, Review of randomised controlled trials of traditional Chinese medicine. BMJ (Clinical research ed) 319, 160–161 (1999)CrossRefGoogle Scholar
  52. X.L. Tong, Q. Ni, F.M. Lian, J.Q. Hu, F.H. Yu, Y. Ou, Q. Xue, Z. Jiang, S.T. Wu, H. Jiang, T.S. Gao, (2009)Google Scholar
  53. D. Topkis, Supermodularity and Complementarity (Princeton University Press, Princeton, 1998)Google Scholar
  54. M.R. Trusheim, E.R. Berndt, F.L. Douglas, Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nat. Rev. Drug Discov. 6, 287–293 (2007)CrossRefGoogle Scholar
  55. J.P. Vader, Randomised controlled trials: a user’s guide. BMJ (Clinical research ed) 317, 1258 (1998)CrossRefGoogle Scholar
  56. H. van Wietmarschen, K. Yuan, C. Lu, P. Gao, J. Wang, C. Xiao, X. Yan, M. Wang, J. Schroen, A. Lu, G. Xu, J. van der Greef, Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients. J. Clin. Rheumatol. 15, 330–337 (2009)CrossRefGoogle Scholar
  57. N. Vipond, Intervertebral disc replacement (2007), http://www.acc.co.nz/PRD_EXT_CSMP/groups/external_communications/documents/reports_results/prd_ctrb091239.pdf. Accessed 28 Sep 2010
  58. J.A. Walters, E.H. Walters, R. Wood-Baker, Oral corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst. Rev., CD005374 (2005)Google Scholar
  59. H. Wang, H.C. Shang, J.H. Zhang, J. Chen, B.Z. Sun, D.D. Shang, Y.Z. Xiang, H.B. Cao, M. Ren, L.P. Cuo, B.L. Zhang, Niuhuang Jiangya preparation for treatment of essential hypertension: a systematic review. Liaoning J. Tradit. Chin. Med. 35, 649–652 (2008) [in Chinese]Google Scholar
  60. S.Z. Wang, H.L. Lin, H.M. Song, W.H. Zhong, T.X. Wu, G.J. Liu, S.Q. Chen, Conservative in the treatment of protrusion of cervical vertebra intervertebral disc: a systematic review. Chin. J. Evid. Based Med. 9, 331–336 (2009) [in Chinese]Google Scholar
  61. L. Wang, R.M. Zhang, G.Y. Liu, B.L. Wei, Y. Wang, H.Y. Cai, F.S. Li, Y.L. Xu, S.P. Zheng, G. Wang, Chinese herbs in treatment of influenza: a randomized, double-blind, placebo-controlled trial. Respir. Med. 104, 1362–1369 (2010)CrossRefGoogle Scholar
  62. C. Wang, B. Cao, Q.Q. Liu, Z.Q. Zou, Z.A. Liang, L. Gu, J.P. Dong, L.R. Liang, X.W. Li, K. Hu, X.S. He, Y.H. Sun, Y. An, T. Yang, Z.X. Cao, Y.M. Guo, X.M. Wen, Y.G. Wang, Y.L. Liu, L.D. Jiang, Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial. Ann. Intern. Med. 155, 217–225 (2011)CrossRefGoogle Scholar
  63. Y.G. Wang, M. Jiang, R.B. Wang, Q.L. Zha, S.J. Zhang, G.Q. Zhou, X.W. Li, Y.Y. Wang, A.P. Lv, Duration of viral shedding of influenza A (H1N1) virus infection treated with oseltamivir and/or traditional Chinese medicine in China: a retrospective analysis. J. Tradit. Chin. Med. (Chung i tsa chih ying wen pan)//sponsored by All-China Association of Traditional Chinese Medicine, Academy of Traditional Chinese Medicine 32, 148–155 (2012)Google Scholar
  64. L.S. Wei Jinqi, H. Weining, Compared with Tagamet in treating chronic gastric ulcer. Chin. J. Integr. Tradit. West. Med. S1, 29–30 (1994)Google Scholar
  65. J.A. Wessels, S.M. van der Kooij, S. le Cessie, W. Kievit, P. Barerra, C.F. Allaart, T.W. Huizinga, H.J. Guchelaar, A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis. Arthritis Rheum. 56, 1765–1775 (2007)CrossRefGoogle Scholar
  66. B. Wu, M. Liu, S. Zhang, Dan Shen agents for acute ischaemic stroke. Cochrane Database Syst. Rev. 18(2), CD004295 (2007)Google Scholar
  67. T. Wu, Y. Li, Z. Bian, G. Liu, D. Moher, Randomized trials published in some Chinese journals: how many are randomized? Trials 10, 46 (2009)CrossRefGoogle Scholar
  68. J.X. Xie, H.T. Hu, D.N. Xiao, H.Z. Xie, C.B. Zhu, W.T. Yang, X.X. Huang, X.J. He, G.R. Liang, Z.G. Wang, Safety and efficacy of Qianliean Suppository for chronic prostatitis of damp-heat and blood-stasis syndrome: a randomized, single-blind, parallel controlled, multi-centered phase III clinical trial. Zhonghua Nan Ke Xue 15, 1049–1052 (2009)Google Scholar
  69. D.Y. Xu, J. Shu, Q.Y. Huang, L. Liu, S.P. Zhao, A comparative study of the efficacy and safety Zhibitai and atorvastatin. Zhonghua Nei Ke Za Zhi 49, 392–395 (2010a)Google Scholar
  70. D.Y. Xu, J. Shu, Q.Y. Huang, B. Wasti, C. Chen, L. Liu, S.P. Zhao, Evaluation of the lipid lowering ability, anti-inflammatory effects and clinical safety of intensive therapy with Zhibitai, a Chinese traditional medicine. Atherosclerosis 211, 237–241 (2010b)CrossRefGoogle Scholar
  71. Y.H. Xu, J.H. Wang, F.X. Yang, X.Z. He, 8. The effects of respiratory rehabilitation training on pulmonary function and quality of life of patients with COPD. Chin. J. Rehabil. 2, 42–44 (2010c)Google Scholar
  72. H. Yang, J. Yang, Z. Wen, Q. Zha, G. Nie, X. Huang, C. Zhang, A. Lu, M. Jiang, X. Wang, Effect of combining therapy with traditional Chinese medicine-based psychotherapy and herbal medicines in women with menopausal syndrome: a randomized controlled clinical trial. Evid. Based Complement. Alternat. Med.: eCAM 2012, 354145 (2012)Google Scholar
  73. H.G. Yi, G.Z. Huang, G.J. Liu, Efficacy and safety of Levoamlodipine Besylate for essential hypertension: a systematic review. Chin. J. Evid. Based Med. 8, 543–550 (2008) [in Chinese]Google Scholar
  74. Z. Yu, G. Wang, G.Y. Chen, J. Chang, Y. Zhang, R.M. Zhang, Muo-luo-dan. Concentrated pill in treatment of chronic atrophic gastritis (the stomach-yin of deficiency and stagnated blood of stomach meridian): a prospective, randomized, controlled trial. West China Med. J. 2, 287–289 (2007)Google Scholar
  75. Q. Zha, S. Lin, C. Zhang, C. Chang, H. Xue, C. Lu, M. Jiang, Y. Liu, Z. Xiao, W. Liu, Y. Shang, J. Chen, M. Wen, A. Lu, Xiaoqinglong granules as add-on therapy for asthma: latent class analysis of symptom predictors of response. Evid. Based Complement. Alternat. Med.: eCAM 2013, 759476 (2013)Google Scholar
  76. L. Zhao, K. Chan, Building a bridge for integrating Chinese medicine into conventional healthcare: observations drawn from the development of the Chinese quality of life instrument. Am. J. Chin. Med. 33, 897–902 (2005)CrossRefGoogle Scholar
  77. L. Zhao, A.Y. Li, H. Lv, F.Y. Liu, F.H. Qi, Traditional Chinese medicine Ningdong granule: the beneficial effects in Tourette’s disorder. J. Int. Med. Res. 38, 169–175 (2010)CrossRefGoogle Scholar
  78. W. Zhou, Y.Q. Zhong, H.M. Yang, H.L. Jiang, J.J. Fu, W.B. Zhang, B. Mao, Traditional Chinese medicine in the treatment of chronic obstructive pulmonary disease in stable stage: a systematic review of randomized controlled trials. Chin. J. Evid. Based Med. 9, 311–318 (2009) [in Chinese]Google Scholar
  79. C.X. Zhou, X. Cui, X.Q. Li, H.L. Zeng, H.H. Ni, C.S. Huang, J. Wu, J.C. Shi, M.L. Feng, Y.G. Wu, Clinical research on combined herbal medicine and acupuncture in treating poststroke depression. Shanghai J. Tradit. Chin. Med. 5, 52–54 (2010a)Google Scholar
  80. C.Y. Zhou, J.Y. Tang, D.Y. Fang, Clinical study on active rheumatoid arthritis treated with simiao xiaobi decoction. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi (Chinese journal of integrated traditional and Western medicine//Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban) 30, 275–279 (2010b)Google Scholar
  81. J. Zhu, X. Wan, Y. Zhu, X. Ma, Y. Zheng, T. Zhang, Evaluation of salidroside in vitro and in vivo genotoxicity. Drug Chem. Toxicol. 33, 220–226 (2010)CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  • Kelvin Chan
    • 1
    • 2
  • Josiah Poon
    • 3
  • Simon K. Poon
    • 3
  • Miao Jiang
    • 4
  • Aiping Lu
    • 4
  1. 1.Faculty of PharmacyThe University of SydneySydneyAustralia
  2. 2.National Institute of Complementary MedicineUniversity of Western SydneyRichmondAustralia
  3. 3.School of Information TechnologiesThe University of SydneySydneyAustralia
  4. 4.Institute of Basic Research in Clinical MedicineChina Academy of Chinese Medical SciencesBeijingChina

Personalised recommendations